title: Accelerated ovarian failure: a novel, chemically induced animal model of menopause.
abstract: Current rodent models of menopause fail to adequately recapitulate the menopause transition. The intact aging model fails to achieve very low estrogen levels, and the ovariectomy model lacks a perimenopause phase. A new rodent model of accelerated ovarian failure (AOF) successfully replicates human perimenopause and postmenopause, including estrous acyclicity and fluctuating, followed by undetectable, estrogen levels, and allows for the dissociation of the effects of hormone levels from the effects of aging. In this model, an ovotoxic chemical, 4-vinylcyclohexene diepoxide (VCD), selective for primary and primordial follicles, is injected intraperitonelly in animals for 15 days. As the mature follicle population is depleted through natural cycling, ovarian failure follows increasing periods of acyclity. Administered at low doses, VCD specifically causes apoptotic cell death of primordial follicles but does not affect other peripheral tissues, including the liver and spleen, nor does it affect brain inflammation markers. In addition to reducing confounds associated with genetic and surgical manipulations, the AOF model maintains the presence of ovarian tissue which importantly parallels to the menopause transition in humans. The VCD injection procedure can be applied to studies using transgenic or knockout mice strains, or in other disease-state models (e.g., ischemia, atherosclerosis, or diabetes). This AOF model of menopause will generate new insights into women's health particularly in determining the critical periods (i.e., a window of opportunity) during perimenopause for restoring ovarian hormones for the most efficacious effect on memory and mood disorders as well as other menopausal symptoms.
authors.affiliation: Division of Neurobiology, Department of Neurology and Neuroscience, Weill Cornell Medical College, New York, NY 10065, USA. tav2002@med.cornell.edu
authors.forename: Tracey A
authors.initials: TA
authors.lastname: Van Kempen
authors.forename: Teresa A
authors.initials: TA
authors.lastname: Milner
authors.forename: Elizabeth M
authors.initials: EM
authors.lastname: Waters
mesh_terms: D000818:Animals; D053138:Cyclohexenes / Q000633:toxicity*; D005260:Female; D006801:Humans; D008593:Menopause / Q000187:drug effects / Q000378:metabolism*; D023421:Models, Animal; D010052:Ovariectomy; D017698:Postmenopause / Q000187:drug effects / Q000378:metabolism; D016649:Primary Ovarian Insufficiency / Q000139:chemically induced* / Q000378:metabolism*; D013997:Time Factors; D014753:Vinyl Compounds / Q000633:toxicity*
chemical_list: D053138:Cyclohexenes; D014753:Vinyl Compounds; C012606:4-vinyl-1-cyclohexene dioxide